(NASDAQ:SYBT), LOUISVILLE, Ky., Jan. 23, 2025 (GLOBE NEWSWIRE) — Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, today announced that Ja Hillebrand, Chairman and CEO, and T. Clay […]
NEW YORK, NY / ACCESSWIRE / January 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Neumora Therapeutics, Inc. ("Neumora Therapeutics, Inc.") (NASDAQ:NMRA) concerning possible violations of federal securities laws. On January 2, 2025, Neumora announced its experimental depression treatment failed in the first of three studies planned by
NEW YORK, NY / ACCESS Newswire / January 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Novo Nordisk A/S ("Novo Nordisk A/S") (NYSE:NVO) concerning possible violations of federal securities laws. On December 20, 2024, Novo issued a press release announcing the below-expected results of their "REDEFINE 1" trial,
NEW YORK, NY / ACCESS Newswire / January 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Signet Jewelers Limited ("Signet") (NYSE:SIG) concerning possible violations of federal securities laws. On January 14, 2025, Signet issued a press release announcing the company’s holiday sales results, comprising the 10-week period ending
NEW YORK, NY / ACCESS Newswire / January 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ModivCare Inc. ("ModivCare Inc.") (NASDAQ:MODV) concerning possible violations of federal securities laws. On September 12, 2024, ModivCare filed a press release on a Form 8-K. Therein, the Company announced that it would
NEW YORK, NY / ACCESS Newswire / January 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDAQ:VRTX) concerning possible violations of federal securities laws. On December 19, 2024, the company reported disappointing results from its RewinD-LB Phase 2b clinical trial for the pain
NEW YORK, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=124579&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / January 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Genuine Parts Company ("Genuine Parts Company") (NYSE:GPC) concerning possible violations of federal securities laws. On October 22, 2024, Genuine reported 3Q 2024 earnings that fell well below expectations and then lowered its
NEW YORK, NY / ACCESSWIRE / January 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Newmont Corporation ("Newmont Corporation") (NYSE:NEM) concerning possible violations of federal securities laws. On October 23, 2024, Newmont reported 3Q 2024 earnings that fell below expectations, as well as rising operational costs. Management attributed
NEW YORK, NY / ACCESSWIRE / January 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Constellation Brands, Inc. ("Constellation Brands, Inc.") (NYSE:STZ) concerning possible violations of federal securities laws. On January 10, 2025, Constellation issued a press release announcing the company’s third quarter fiscal year 2025 results, showcasing